Abstract
Mutations in DNA mismatch repair (MMR) genes are associated with increased genomic instability and susceptibility to cancer. Mice rendered deficient in either Mlh1 or Pms2 as a result of gene targeting are prone to tumorigenesis, particularly, lymphomas. In addition, although Mlh1−/− mice also develop small intestinal adenomas and adenocarcinomas, Pms2−/− animals remain free of such tumors. To establish whether this phenotypic dichotomy might be associated with a quantitative and/or qualitative difference in genomic instability in these mice, we determined small intestinal epithelial cell DNA mutant frequency and mutation spectrum using a transgenic λ-phage lacI reporter system. Mutant frequencies obtained from both Mlh1−/− and Pms2−/− mice revealed elevations of 18- and 13-fold, respectively, as compared to their wild-type littermates. Interestingly, we found that C : G→T : A transitions were significantly elevated in Mlh1−/− mice, accounting in large measure for the 1.5-fold lacI mutant frequency increase seen in these animals. We hypothesize that the increased level of C : G→T : A mutations may explain, in part, why Mlh1−/− mice, but not Pms2−/− mice, develop small intestinal tumors. Furthermore, the difference in the lacI mutational spectrum of Mlh1−/− and Pms2−/− mice suggests that other MutL-like heterodimers may play important roles in the repair of G : T mispairs arising within murine small intestinal epithelial cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Andrew SE, Pownall S, Fox J, Hsiao L, Hambleton J, Penney JE, Kohler SW and Jirik FR. . 1996 Mutat. Res. 357: 57–66.
Baker SM, Bronner CE, Zhang L, Plug AW, Robatzek M, Warren G, Elliott EA, Yu J, Ashley T and Arnheim N. . 1995 Cell 82: 309–319.
Baker SM, Plug AW, Prolla TA, Bronner CE, Harris AC, Yao X, Christie DM, Monell C, Arnheim N, Bradley A, Ashley T and Liskay RM. . 1996 Nat. Genet. 13: 336–342.
The Big Blue Website . 11 October, 1999, revision date. Maintained by J de Boer at the Center for Environmental Health of the University of Victoria, BC, [Online] http://eden.ceh.uvic.ca/protocol.htm edition, [June 27, 2000, last date accessed.]
de Boer JG and Glickman BW. . 1998 Genetics 148: 1441–1451.
Di Cristofano A, Pesce B, Cordon-Cardo C and Pandolfi PP. . 1998 Nat. Genet. 19: 348–355.
Dogliotti E. . 1996 Carcinogenesis 17: 2113–2118.
Edelmann W, Yang K, Umar A, Heyer J, Lau K, Fan K, Liedtke W, Cohen PE, Kane MF, Lipford JR, Yu N, Crouse GF, Pollard JW, Kunkel T, Lipkin M, Kolodner R and Kucherlapati R. . 1997 Cell 91: 467–477.
Flores-Rozas H and Kolodner RD. . 1998 Proc. Natl. Acad. Sci. USA 95: 12404–12409.
Guerrette S, Acharya S and Fishel R. . 1999 J. Biol. Chem. 274: 6336–6341.
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB. . 1998 Proc. Natl. Acad. Sci. USA 95: 6870–6875.
Heyer J, Yang K, Lipkin M, Edelmann W and Kucherlapati R. . 1999 Oncogene 18: 5325–5333.
Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, Zheng S, Willson JK, Markowitz SD, Morin P, Kinzler KW, Vogelstein B and Dunlop MG. . 1996 Proc. Natl. Acad. Sci. USA 93: 9049–9054.
Jiricny J. . 1998 Mutat. Res. 409: 107–121.
Kato T, Yatagai F, Glickman BW, Tachibana A and Ikenaga M. . 1998 Mutat. Res. 422: 279–283.
Kinzler KW and Vogelstein B. . 1996 Cell 87: 159–170.
Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL and Short JM. . 1991 Proc. Natl. Acad. Sci. USA 88: 7958–7962.
Kohler SW, Provost GS, Kretz PL, Fieck A, Sorge JA and Short JM. . 1990 Genet. Anal. Tech. Appl. 7: 212–218.
Kolodner RD. . 1995 Trends Biochem. Sci. 20: 397–401.
Kolodner RD and Marsischky GT. . 1999 Curr. Opin. Genet. Dev. 9: 89–96.
Lazar V, Grandjouan S, Bognel C, Couturier D, Rougier P, Bellet D and Bressac-de Paillerets B. . 1994 Hum. Mol. Genet. 3: 2257–2260.
Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS and Ho JC. . 1999 Cancer Res. 59: 159–164.
Lipkin SM, Wang V, Jacoby R, Banerjee-Basu S, Baxevanis AD, Lynch HT, Elliott RM and Collins FS. . 2000 Nat. Genet. 24: 27–35.
Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Moller P and King MC. . 1997 Am. J. Hum. Genet. 61: 1254–1260.
Marra G and Schar P. . 1999 Biochem. J. 338: 1–13.
Modrich P and Lahue R. . 1996 Annu. Rev. Biochem. 65: 101–133.
Narayanan L, Fritzell JA, Baker SM, Liskay RM and Glazer PM. . 1997 Proc. Natl. Acad. Sci. USA 94: 3122–3127.
Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ and Thomas G. . 1997 Proc. Natl. Acad. Sci. USA 94: 12122–12127.
Prolla TA. . 1998 Curr. Opin. Cell. Biol. 10: 311–316.
Prolla TA, Baker SM, Harris AC, Tsao JL, Yao X, Bronner CE, Zheng B, Gordon M, Reneker J, Arnheim N, Shibata D, Bradley A and Liskay RM. . 1998 Nat. Genet. 18: 276–279.
Prolla TA, Pang Q, Alani E, Kolodner RD and Liskay RM. . 1994 Science 265: 1091–1093.
Raschle M, Marra G, Nystrom-Lahti M, Schar P and Jiricny J. . 1999 J. Biol. Chem. 274: 32368–32375.
Ricciardone MD, Ozcelik T, Cevher B, Ozdag H, Tuncer M, Gurgey A, Uzunalimoglu O, Cetinkaya H, Tanyeli A, Erken E and Ozturk M. . 1999 Cancer Res. 59: 290–293.
Simpkins SB, Bocker T, Swisher EM, Mutch DG, Gersell DJ, Kovatich AJ, Palazzo JP, Fishel R and Goodfellow PJ. . 1999 Hum. Mol. Genet. 8: 661–665.
Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M and Mak TW. . 1998 Curr. Biol. 8: 1169–1178.
Toft NJ and Arends MJ. . 1998 J. Pathol. 185: 123–129.
Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E and Puisieux A. . 1999a Cancer Res. 59: 294–297.
Wang Q, Lasset C, Desseigne F, Saurin JC, Maugard C, Navarro C, Ruano E, Descos L, Trillet-Lenoir V, Bosset JF and Puisieux A. . 1999b Hum. Genet. 105: 79–85.
Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ and Bodmer WF. . 1999 Proc. Natl. Acad. Sci. USA 96: 10296–10301.
Yang Y, Karthikeyan R, Mack SE, Vonarx EJ and Kunz BA. . 1999 Mol. Gen. Genet. 261: 777–787.
Yao X, Buermeyer AB, Narayanan L, Tran D, Baker SM, Prolla TA, Glazer PM, Liskay RM and Arnheim N. . 1999 Proc. Natl. Acad. Sci. USA 96: 6850–6855.
Acknowledgements
We thank L Spence for genotyping the mice, LA Waddleton and C Fletch for maintaining the various lines, and K Fichter at the Canadian Genetic Disease Network DNA Sequencing Core Facility. We are grateful to Dr SE Andrew for critically evaluating this manuscript. This study was supported by Grant #007137 from the National Cancer Institute of Canada, with funds from the Canadian Cancer Society (to FR Jirik), and NIH grant R01 GM32741 (to RM Liskay). A Baross-Francis was the recipient of a Natural Sciences and Engineering Research Council of Canada Graduate Scholarship.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baross-Francis, A., Makhani, N., Liskay, R. et al. Elevated mutant frequencies and increased C : G→T : A transitions in Mlh1−/− versus Pms2−/− murine small intestinal epithelial cells. Oncogene 20, 619–625 (2001). https://doi.org/10.1038/sj.onc.1204138
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1204138
Keywords
This article is cited by
-
Ikaros is a mutational target for lymphomagenesis in Mlh1-deficient mice
Oncogene (2007)
-
Chloroplast DNA base substitutions: an experimental assessment
Molecular Genetics and Genomics (2005)
-
Mutational-reporter transgenes rescued from mice lacking either Mgmt, or both Mgmt and Msh6 suggest that O6-alkylguanine-induced miscoding does not contribute to the spontaneous mutational spectrum
Oncogene (2004)
-
Elevated mutant frequencies and predominance of G:C to A:T transition mutations in Msh6−/− small intestinal epithelium
Oncogene (2002)
-
Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2−/− mice
Oncogene (2002)